Barclays’s Zogenix, Inc. ZGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-100
Closed -$5K 6768
2019
Q4
$5K Buy
+100
New +$4.58K ﹤0.01% 6183
2019
Q3
Sell
-35,400
Closed -$1.69M 7504
2019
Q2
$1.69M Buy
+35,400
New +$1.43M ﹤0.01% 3120
2018
Q3
Sell
-27,900
Closed -$1.23M 7694
2018
Q2
$1.23M Buy
+27,900
New +$1.15M ﹤0.01% 3056
2017
Q4
Sell
-782,600
Closed -$27.4M 7370
2017
Q3
$27.4M Buy
+782,600
New +$10.6M 0.03% 530

Barclays's ZGNX Position: Q1 2022 in Review

Barclays sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 141,726 shares — an estimated $2.3M sold.

Barclays first reported a position in ZGNX in Q2 2013 and held it in 35 quarters. The position peaked at $3.96M in Q1 2018. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.

  • Barclays reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
  • Barclays sold 141,726 Zogenix, Inc. shares in Q1 2022, an estimated $2.3M.
  • Barclays first reported a position in Zogenix, Inc. in Q2 2013 and held it in 35 quarters.
  • Barclays's Zogenix, Inc. position peaked at $3.96M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.